October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...
OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...
October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 23, 2007 - Hologic Inc.
October 22, 2007 – Philips highlighted the integration of Volcano’s IVUS into its new Xper system and TrueView’s ability ...
October 22, 2007 - Implantation of the CYPHER Sirolimus-eluting Coronary Stent by Cordis Corp. used to treat completely ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 22, 2007 - GE Healthcare highlighted the advantages of its digital flat panel Biplane imaging systems, the ...
October 22, 2007 – Stent thrombosis rates through one year were low for both the TAXUS Express2 Paclitaxel-Eluting ...
The HI VISION 5500 fully digital ultrasound system reportedly delivers the latest generation of signal processing ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Ever since the BASKET-LATE study came out suggesting an increase in the rate of death and myocardial infarction in ...
October 18, 2007 - At TCT 2007, Radi Medical Systems Inc. focuses on the Femostop HD Femoral Compression System, that with the addition of a hemostatic dressing, promotes dual-action hemostasis, reportedly reducing the need for stocking multiple hemostasis products.
October 18, 2007 - Cordis Corp. will present clinical data backing the CYPHER Sirolimus-eluting coronary stent at the ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 18, 2007 - Abbott announced that trial results for ABSORB, the world’s first clinical trial evaluating the safety and performance of a fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease, are positive.
October 18, 2007 - Possis Medical Inc. featured the newest and the most important advancements in its "Complete Solution for Thrombus" at TCT 2007, including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
October 18, 2007 - Vascular Solution Inc. spotlights its Guardian hemostasis valve and Gopher Support Catheter at TCT ...